Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2004 054 850.2 |
| 96 | EP file number | EAKZ | 18 18 6018.0 |
| 97 | EP publication number | EPN | 3434261 |
| 54 | Designation/title | TI | FORMULIERUNGEN MIT NANOPARTIKULÄREM MELOXICAM |
| 51 | IPC main class | ICM
(ICMV) | A61K 9/14 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/5415 (2006.01) |
| 22 | DE application date | DAT | Feb 27, 2004 |
| 96 | EP application date | EAT | Feb 27, 2004 |
| 43 | Date of first publication | OT | Jan 30, 2019 |
| Date of publication of grant | PET | Oct 28, 2020 |
| 71/73 | Applicant/owner | INH | Baudax Bio, Inc., Malvern, PA, US |
| 72 | Inventor | IN | Cooper, Eugene R., Berwyn, PA 19312, US; Ryde, Tuula, Malvern, PA 19355, US; Pruitt, John D., Suwanee, GA 30024, US; Kline, Laura, Harleysville, PA 19438, US |
| 74 | Representative | VTR | Wuesthoff & Wuesthoff, Patentanwälte PartG mbB, 81541 München, DE |
| Address for service | | Wuesthoff & Wuesthoff Patentanwälte PartG mbB, 81541 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
450705 P
Mar 3, 2003
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003434261A1
Searchable text:
EP000003434261A1
Original document:
EP000003434261B1
Searchable text:
EP000003434261B1 |
| 43 | Date of first publication | EVT | Jan 30, 2019 |
| Date of the first transfer into DPMAregister | EREGT | Jan 30, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 23, 2023
(Show all update days)(Hide all update days)- Jan 30, 2019
- Date of the first transfer into DPMAregister
|
